ARS Pharmaceuticals, Inc. (SPRY)
Nasdaq: SPRY · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2016
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 9, 2026 | Mar 20, 2025 | Mar 21, 2024 | Mar 23, 2023 | Mar 31, 2022 | Mar 29, 2021 |
| Revenue | 84,278 | 89,149 | 30 | 1,316 | 5,506 | · |
| For lenders | ||||||
| Net interest income | · | · | · | · | 106 | -29 |
| Cost of revenue | · | · | 0 | · | · | · |
| Research and development | 13,181 | 19,580 | 20,266 | 18,376 | 20,273r | 24,577 |
| Selling, general and administrative | 230,122 | 71,675 | 47,284r | 603 | · | · |
| General and administrative | · | · | 47,284 | 18,456 | 4,687r | 8,341 |
| Total operating expenses | 263,726 | 92,232 | 67,550 | 36,832 | 24,960r | 32,918 |
| Total costs and expenses | · | 2,066 | 1,796 | 2,144 | · | · |
| Operating income | -179,448 | -3,083 | -67,520 | -35,516 | -19,454r | -32,918 |
| Other income (expense), net | 8,070 | 11,369 | 13,155 | 974 | -789 | · |
| Total non-operating income (expense) | · | · | · | 834 | -789 | · |
| Income before income taxes | -171,378 | 8,286 | -54,365 | · | · | · |
| Income tax expense | -80 | 288 | 0 | 0 | 0 | 0 |
| Net income | -171,298 | 7,998 | -54,365 | -34,682 | -20,243r | -32,947 |
| Earnings per share, basic | -1.74 | 0.08 | -0.57 | -0.87 | -0.70 | · |
| Earnings per share, diluted | -1.74 | 0.08 | -0.57 | -0.87 | -0.70 | · |
| Earnings per share, basic and diluted | · | · | · | · | -2.56 | -11.33 |
| Weighted average shares, basic | 98,566,481 | 96,936,661 | 95,215,322 | 39,956,043 | 28,872,242 | · |
| Weighted average shares, diluted | 98,566,481 | 102,390,828 | 95,215,322 | 39,956,043 | 28,872,242 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 34,926,403 | 2,907,542 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:OperatingCostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted